BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32164600)

  • 41. [Prognostic Value of Recurrent Molecular Genetics and Epigenetics Abnormity in T Lymphoblastic Lymphoma / Leukemia -Review].
    Guan W; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):587-591. PubMed ID: 28446316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the Idylla KRAS and NRAS mutation test in colorectal cancer tissue.
    Zekri J; Baghdadi MA; Alardati H; Khallaf H; Kabanja JH
    Exp Mol Pathol; 2019 Oct; 110():104270. PubMed ID: 31207216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomic and Clinical Analysis of Children with Acute Lymphoblastic Leukemia.
    Liu Y; Nuriding H; Zhao L; Wang X; Yue Y; Song Y; Yan M
    Comput Math Methods Med; 2022; 2022():7904293. PubMed ID: 36017149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted next-generation sequencing for the detection of cancer-associated somatic mutations in adenomyosis.
    Chao A; Wu RC; Lin CY; Lee LY; Tsai CL; Lee YS; Wang CJ
    J Obstet Gynaecol; 2023 Dec; 43(1):2161352. PubMed ID: 36708516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency of FLT3 mutations in childhood acute lymphoblastic leukemia.
    Braoudaki M; Karpusas M; Katsibardi K; Papathanassiou Ch; Karamolegou K; Tzortzatou-Stathopoulou F
    Med Oncol; 2009 Dec; 26(4):460-2. PubMed ID: 19085113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical validation of coexisting driver mutations in colorectal cancers.
    Zheng G; Tseng LH; Haley L; Ibrahim J; Bynum J; Xian R; Gocke CD; Eshleman JR; Lin MT
    Hum Pathol; 2019 Apr; 86():12-20. PubMed ID: 30481508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation.
    Kong G; Du J; Liu Y; Meline B; Chang YI; Ranheim EA; Wang J; Zhang J
    J Biol Chem; 2013 Jun; 288(25):18219-27. PubMed ID: 23673656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
    Cosgarea I; Ugurel S; Sucker A; Livingstone E; Zimmer L; Ziemer M; Utikal J; Mohr P; Pfeiffer C; Pföhler C; Hillen U; Horn S; Schadendorf D; Griewank KG; Roesch A
    Oncotarget; 2017 Jun; 8(25):40683-40692. PubMed ID: 28380455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Panel-based next-generation sequencing identifies prognostic and actionable genes in childhood acute lymphoblastic leukemia and is suitable for clinical sequencing.
    Ishida H; Iguchi A; Aoe M; Takahashi T; Tamefusa K; Kanamitsu K; Fujiwara K; Washio K; Matsubara T; Tsukahara H; Sanada M; Shimada A
    Ann Hematol; 2019 Mar; 98(3):657-668. PubMed ID: 30446805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of a new heterozygous germline ETV6 mutation in a case with hyperdiploid acute lymphoblastic leukemia.
    Duployez N; Abou Chahla W; Lejeune S; Marceau-Renaut A; Letizia G; Boyer T; Geffroy S; Peyrouze P; Grardel N; Nelken B; Michel G; Bertrand Y; Preudhomme C
    Eur J Haematol; 2018 Jan; 100(1):104-107. PubMed ID: 29034503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
    Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells.
    Spinella JF; Cassart P; Garnier N; Rousseau P; Drullion C; Richer C; Ouimet M; Saillour V; Healy J; Autexier C; Sinnett D
    BMC Cancer; 2015 Sep; 15():621. PubMed ID: 26345285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies.
    Papuc SM; Erbescu A; Cisleanu D; Ozunu D; Enache C; Dumitru I; Lupoaia Andrus E; Gaman M; Popov VM; Dobre M; Stanca O; Angelescu S; Berbec N; Colita A; Vladareanu AM; Bumbea H; Arghir A
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34070898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR.
    Nagakubo Y; Hirotsu Y; Amemiya K; Oyama T; Mochizuki H; Omata M
    BMC Med Genomics; 2019 Nov; 12(1):162. PubMed ID: 31711486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome sequencing of lymphoid malignancies.
    Mullighan CG
    Blood; 2013 Dec; 122(24):3899-907. PubMed ID: 24041576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation.
    Suzuki M; Abe A; Kiyoi H; Murata M; Ito Y; Shimada K; Morishita Y; Kinoshita T; Naoe T
    Leukemia; 2006 Jun; 20(6):1168-9. PubMed ID: 16557239
    [No Abstract]   [Full Text] [Related]  

  • 59. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.
    Spencer DH; Abel HJ; Lockwood CM; Payton JE; Szankasi P; Kelley TW; Kulkarni S; Pfeifer JD; Duncavage EJ
    J Mol Diagn; 2013 Jan; 15(1):81-93. PubMed ID: 23159595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.